Products
Geftessa
Pharmacotherapeutic group
Antitumor agents; epidermal growth factor receptor (EGFR) tyrosine kinase inhibitorsInternational name
GefitinibDosage form
film-coated tabletsGefitinib, being a selective inhibitor of epidermal growth factor receptor tyrosine kinase, the expression of which is observed in many solid tumors, inhibits tumor growth, metastasis and angiogenesis, and accelerates apoptosis of tumor cells. Inhibits the growth of various human tumor cell lines and increases the antitumor activity of chemotherapeutic drugs, radiation and hormonal therapy.